CAV3 and muscular dystrophy: The aim of this study is to evaluate the effectiveness of ATCOL-mediated local administration of myostatin-targeting siRNA into skeletal muscles in LGMD1C model mice, and to evaluate this method as a future treatment for muscular dystrophy.